A new risk score can help predict which pancreatic cancer survivors are more likely to suffer a recurrence of their cancer, ...

An AI model significantly improved recurrence risk stratification vs. recurrence score among patients with hormone ...

A new risk score may identify patients with node-negative pancreatic neuroendocrine tumors who face a high risk for ...

RECKGIST score effectively predicts recurrence in neurofibromatosis type 1-associated GISTs, especially for tumors under 30 mm. Larger GISTs (over 30 mm) have a higher risk of metastasis, with ...

Researchers have developed a genomic model that could improve predictions of long-term recurrence in a common form of breast ...

The ICM+ AI model demonstrated superior prognostic value for breast cancer recurrence compared to Oncotype DX, especially for late distant recurrences. Integration of pathomic imaging in the ICM+ ...

Please provide your email address to receive an email when new articles are posted on . Further study is needed to identify potential drivers of the association Low household income appeared ...

Investigators compared patient-reported cancer-related cognitive impairment between pre- and postmenopausal women with breast cancer who received endocrine therapy with or without chemotherapy.

MADISON, Wis., April 28, 2022 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leader in advanced cancer diagnostics, today announced that recommended use of its Oncotype DX Breast Recurrence ...

"We have known that income level is associated with incidence of poor-prognosis triple-negative breast cancer, but our new study presents the first data to show that income level impacts survival even ...

Women with early-stage hormone receptor (HR)-positive breast cancer who had low to intermediate scores on the Oncotype DX Breast Recurrence Score assay did just as well on neoadjuvant endocrine ...

Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients ...